SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $701,000 | +51.1% | 29,514 | +14.3% | 0.07% | -46.8% |
| Q1 2020 | $464,000 | -44.9% | 25,814 | -27.3% | 0.12% | -67.2% |
| Q4 2019 | $842,000 | -32.7% | 35,500 | +13.1% | 0.38% | -33.7% |
| Q4 2017 | $1,251,000 | -51.1% | 31,400 | -50.9% | 0.57% | +35.7% |
| Q3 2017 | $2,560,000 | +33.8% | 64,000 | +44.1% | 0.42% | -35.9% |
| Q2 2017 | $1,914,000 | – | 44,409 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 7,641,250 | $107,207,000 | 7.06% |
| HealthInvest Partners AB | 782,746 | $10,982,000 | 6.50% |
| KOPP INVESTMENT ADVISORS LLC | 729,960 | $10,241,000 | 5.51% |
| Murphy Michael R | 1,028,304 | $14,427,000 | 4.96% |
| Opaleye Management Inc. | 460,000 | $6,454,000 | 3.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 511,244 | $7,173,000 | 1.68% |
| Bruce & Co., Inc. | 394,581 | $5,535,000 | 1.42% |
| AlphaOne Investment Services, LLC | 235,065 | $3,297,000 | 1.40% |
| Ranger Investment Management | 1,560,453 | $21,893,000 | 1.23% |
| NORTHPOINTE CAPITAL LLC | 584,753 | $8,204,000 | 1.07% |